Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | metallo- peptidase, Clan MG, Family M24 | 0.0084 | 0 | 0.5 |
Loa Loa (eye worm) | acetylcholinesterase 1 | 0.0212 | 1 | 1 |
Echinococcus granulosus | acetylcholinesterase | 0.0212 | 1 | 1 |
Chlamydia trachomatis | methionine aminopeptidase | 0.0084 | 0 | 0.5 |
Trypanosoma brucei | methionine aminopeptidase, type I, putative | 0.0084 | 0 | 0.5 |
Leishmania major | methionine aminopeptidase, putative,metallo-peptidase, Clan MG, Family M24 | 0.0084 | 0 | 0.5 |
Plasmodium falciparum | methionine aminopeptidase 1a, putative | 0.0084 | 0 | 0.5 |
Mycobacterium tuberculosis | Methionine aminopeptidase MapB (map) (peptidase M) | 0.0084 | 0 | 0.5 |
Plasmodium vivax | methionine aminopeptidase 1a, putative | 0.0084 | 0 | 0.5 |
Treponema pallidum | methionine aminopeptidase (map) | 0.0084 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0212 | 1 | 1 |
Trypanosoma cruzi | metallo- peptidase, Clan MG, Family M24 | 0.0084 | 0 | 0.5 |
Mycobacterium leprae | PROBABLE METHIONINE AMINOPEPTIDASE MAPA (MAP) (PEPTIDASE M) (MetAP) | 0.0084 | 0 | 0.5 |
Trypanosoma brucei | methionine aminopeptidase, putative | 0.0084 | 0 | 0.5 |
Echinococcus granulosus | carboxylesterase 5A | 0.0212 | 1 | 1 |
Echinococcus multilocularis | acetylcholinesterase | 0.0212 | 1 | 1 |
Echinococcus granulosus | acetylcholinesterase | 0.0212 | 1 | 1 |
Plasmodium vivax | methionine aminopeptidase 1b, putative | 0.0084 | 0 | 0.5 |
Echinococcus multilocularis | carboxylesterase 5A | 0.0212 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0212 | 1 | 1 |
Toxoplasma gondii | methionine aminopeptidase, type i, putative | 0.0084 | 0 | 0.5 |
Mycobacterium tuberculosis | Methionine aminopeptidase MapA (map) (peptidase M) (MetAP) | 0.0084 | 0 | 0.5 |
Mycobacterium ulcerans | methionine aminopeptidase | 0.0084 | 0 | 0.5 |
Mycobacterium leprae | PROBABLE METHIONINE AMINOPEPTIDASE MAPB (MAP) (PEPTIDASE M) | 0.0084 | 0 | 0.5 |
Loa Loa (eye worm) | carboxylesterase | 0.0212 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | methionine aminopeptidase | 0.0084 | 0 | 0.5 |
Mycobacterium ulcerans | methionine aminopeptidase MapB | 0.0084 | 0 | 0.5 |
Plasmodium falciparum | methionine aminopeptidase 1b, putative | 0.0084 | 0 | 0.5 |
Toxoplasma gondii | methionine aminopeptidase | 0.0084 | 0 | 0.5 |
Echinococcus multilocularis | acetylcholinesterase | 0.0212 | 1 | 1 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0212 | 1 | 1 |
Brugia malayi | Carboxylesterase family protein | 0.0212 | 1 | 1 |
Toxoplasma gondii | methionine aminopeptidase | 0.0084 | 0 | 0.5 |
Trypanosoma brucei | metallo- peptidase, Clan MG, Family M24 | 0.0084 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
LD50 (ADMET) | = 0.392 mM kg-1 | Compound was tested in mouse for significant protection against the lethal effects of 2xLD50 of soman without atropine | ChEMBL. | 2913310 |
logD | = -1.08 | Octanol buffer partition coefficient for 0.1M, at pH 7.6 in phosphate buffer | ChEMBL. | 2913310 |
pKa | = 8.06 | Dissociation constant (pKa) (in 0.1 M phosphate buffer) | ChEMBL. | 2913310 |
Survivors (functional) | = 0 | Number of surviving mice after the administration of compound and 11.2 mg/kg of atropine sulfate and 1/16 LD50 of 2-PAM. | ChEMBL. | 2913310 |
Survivors (functional) | = 1 | Number of surviving mice after the administration of compound and 11.2 mg/kg of atropine sulfate and 1/8 LD50 of 2-PAM. | ChEMBL. | 2913310 |
Survivors (functional) | = 2 | Number of surviving mice after the administration of compound and 11.2 mg/kg of atropine sulfate and 1/4 LD50 of 2-PAM. | ChEMBL. | 2913310 |
Survivors (functional) | = 0 | Number of surviving mice after the administration of compound and 11.2 mg/kg of atropine sulfate and 1/16 LD50 of 2-PAM. | ChEMBL. | 2913310 |
Survivors (functional) | = 1 | Number of surviving mice after the administration of compound and 11.2 mg/kg of atropine sulfate and 1/8 LD50 of 2-PAM. | ChEMBL. | 2913310 |
Survivors (functional) | = 2 | Number of surviving mice after the administration of compound and 11.2 mg/kg of atropine sulfate and 1/4 LD50 of 2-PAM. | ChEMBL. | 2913310 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.